A Comparison of 48-Week Treatment Efficacy Between Clevudine and Entecavir in Treatment-Naïve Patients With Chronic Hepatitis B

Hepatology International - India
doi 10.1007/s12072-010-9238-7
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparison of Renal Safety and Efficacy of Telbivudine, Entecavir and Tenofovir Treatment in Chronic Hepatitis B Patients: Real World Experience

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2016English

Constipation During Entecavir Treatment in Chronic Hepatitis B Patients: Two Cases Reports

Archives of Hepatitis Research
2017English

Entecavir Treatment of Chronic Hepatitis D

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
2012English

Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients With Chronic Hepatitis C Infection

Advances in Therapy
MedicinePharmacology
2020English

Evaluation of Long-Term Entecavir Treatment in Stable Chronic Hepatitis B Patients Switched From Lamivudine Therapy

Hepatology International
Hepatology
2010English

Prolonged Entecavir Therapy Is Not Effective for HBeAg Seroconversion in Treatment-Naive Chronic Hepatitis B Patients With a Partial Virological Response

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Changes of Serum sPD-1 Levels in HBeAg-positive Chronic Hepatitis B Patients With Entecavir Treatment and Correlation With Curative E Ect

Turkish Journal of Medical Sciences
Medicine
2018English

Comparison of the Clinical Outcomes Between Antiviral-Naïve Patients Treated With Entecavir and Lamivudine-Resistant Patients Receiving Adefovir Add-On Lamivudine Combination Treatment

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2016English

The Relation Between Entecavir Dose and Therapeutic Effect in the Treatment of Hepatitis B Virus

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy